Skip to content

Partial resection in treatment of lacrimal gland prolapse and associated histopathology study

Partial resection in treatment of lacrimal gland prolapse and associated histopathology study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033928
Enrollment
Unknown
Registered
2020-06-17
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lacrimal gland prolapse

Interventions

experimental group:lacrimal gland partial resection

Sponsors

Tianjin Aier Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with lacrimal gland prolapse, age 15-65 years old; 2. Patients who understand the role of operation and possible complications.

Exclusion criteria

Exclusion criteria: Patients with severe systemic disease and psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
eyelid appearance;pathological characteristics of lacrimal gland resection;

Secondary

MeasureTime frame
recurrence rate;Lacrimal secretion;

Countries

China

Contacts

Public ContactQingji Li

Tianjin Aier Eye Hospital

liqingji@sina.com+86 13920518915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026